Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT04890483

tDCS in Post-Acute COVID-19 Patients With SARDs

Led by University of Sao Paulo · Updated on 2024-12-05

20

Participants Needed

1

Research Sites

185 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Some patients develop "Post-acute COVID-19 syndrome," in which they experience persistent symptoms after recovering from the acute phase of COVID-19 infection. This syndrome may be more significant in patients with systemic autoimmune rheumatic diseases (SARDs) who have been suffering from several symptoms associated to SARDs, such as myalgia, fatigue, and general pains. The transcranial direct current stimulation (tDCS) technique has been frequent, for example, to relieve fatigue and general pains in general population. However, to date, there are no studies evaluating this technique in ARD patients with post-acute COVID-19; therefore, the main objective of the opened study is to evaluate the safety and efficacy of the application of acute tDCS in ARD patients with post-acute COVID-19.

CONDITIONS

Official Title

tDCS in Post-Acute COVID-19 Patients With SARDs

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with well-defined autoimmune rheumatic diseases such as rheumatoid arthritis, systemic sclerosis, Sjögren syndrome, spondyloarthritis, systemic lupus erythematosus, systemic vasculitis, or systemic autoimmune myopathies
  • Presence of fatigue or general pains
Not Eligible

You will not qualify if you...

  • History of cancer
  • Use of a heart pacemaker
  • Presence of metallic clips inside the body
  • Infections with HIV, HTLV-1, or hepatitis
  • Pregnancy
  • History of seizures or epilepsy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Samuel K Shinjo

São Paulo, Brazil

Actively Recruiting

Loading map...

Research Team

S

Samuel K Shinjo, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here